JCR Pharmaceuticals Co., Ltd. (4552.T)
JPY 610.0
(-0.81%)
JPY 610.0
(-0.81%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 42.87 Billion | 34.34 Billion | 51.08 Billion | 30.08 Billion | 24.78 Billion | 23.16 Billion |
| Cost of Revenue | 11.62 Billion | 8.88 Billion | 10.46 Billion | 7.81 Billion | 7.9 Billion | 6.56 Billion |
| Gross Profit | 31.25 Billion | 25.45 Billion | 40.62 Billion | 22.27 Billion | 16.88 Billion | 16.59 Billion |
| Operating Expenses | 23.72 Billion | 20.48 Billion | 20.68 Billion | 14 Billion | 13.63 Billion | 11.62 Billion |
| Selling, General and Administrative Expenses | 12.48 Billion | 11.67 Billion | 13.51 Billion | 8.62 Billion | 7.63 Billion | 7.27 Billion |
| Research and Development Expenses | 11.23 Billion | 8.8 Billion | 7.17 Billion | 5.36 Billion | 5.99 Billion | 4.35 Billion |
| Other Expenses | - | 58 Million | 38 Million | 61 Million | 4 Million | 16 Million |
| Cost and Expenses | 35.33 Billion | 29.36 Billion | 31.14 Billion | 21.81 Billion | 21.53 Billion | 18.19 Billion |
| Operating Income | 7.53 Billion | 4.97 Billion | 19.93 Billion | 8.26 Billion | 3.24 Billion | 4.96 Billion |
| Interest Expense | 86 Million | 44 Million | 45 Million | 42 Million | 22 Million | 21 Million |
| Income Tax Expense | 1.7 Billion | 1.62 Billion | 4.88 Billion | 1.76 Billion | 742 Million | 1.21 Billion |
| Earnings before Tax | 7.24 Billion | 5.41 Billion | 19.4 Billion | 8.65 Billion | 3.42 Billion | 4.92 Billion |
| Net Income | 5.5 Billion | 3.77 Billion | 14.5 Billion | 6.89 Billion | 2.67 Billion | 3.71 Billion |
| Earnings Per Share Basic | 44.13 | 30.34 | 117.26 | 55.80 | 21.72 | 30.17 |
| Earnings Per Share Diluted | 43.92 | 30.22 | 116.79 | 55.52 | 21.59 | 29.99 |
| Weighted Average Shares Outstanding | 124.79 Million | 124.3 Million | 123.72 Million | 123.51 Million | 123.28 Million | 123.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 125.39 Million | 124.83 Million | 124.2 Million | 124.13 Million | 124.04 Million | 123.87 Million |
| Gross Margin | 0.73 | 0.74 | 0.80 | 0.74 | 0.68 | 0.72 |
| EBIT Margin | 0.25 | 0.22 | 0.44 | 0.35 | 0.19 | 0.28 |
| Profit Margin | 0.13 | 0.11 | 0.28 | 0.23 | 0.11 | 0.16 |
| EBITDA | 10.72 Billion | 6.97 Billion | 21.88 Billion | 10.18 Billion | 4.67 Billion | 6.31 Billion |
| Earnings Before Tax Margin | 0.18 | 0.14 | 0.39 | 0.27 | 0.13 | 0.21 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 8.51 Billion | 8.14 Billion | 9.15 Billion | 42.87 Billion | 9.44 Billion | 13.46 Billion |
| Cost of Revenue | 2.25 Billion | 2.28 Billion | 3.19 Billion | 11.62 Billion | 2.54 Billion | 2.51 Billion |
| Gross Profit | 6.25 Billion | 5.85 Billion | 5.95 Billion | 31.25 Billion | 6.9 Billion | 10.94 Billion |
| Operating Expenses | 6.69 Billion | 6.36 Billion | 6.23 Billion | 23.71 Billion | 5.99 Billion | 6.11 Billion |
| Selling, General and Administrative Expenses | 6.69 Billion | 6.36 Billion | 6.23 Billion | - | 3.16 Billion | 2.87 Billion |
| Research and Development Expenses | - | - | 2.87 Billion | - | 2.82 Billion | 3.24 Billion |
| Other Expenses | - | -592 Million | -65 Million | 5 Million | 21 Million | 36 Million |
| Cost and Expenses | 8.95 Billion | 8.65 Billion | 9.43 Billion | 35.33 Billion | 8.53 Billion | 8.63 Billion |
| Operating Income | -443 Million | -510 Million | -277 Million | 7.53 Billion | 911 Million | 4.83 Billion |
| Interest Expense | 37 Million | 26 Million | 23 Million | 86 Million | 23 Million | 21 Million |
| Income Tax Expense | -40 Million | 164 Million | -492 Million | 1.7 Billion | 339 Million | 1.2 Billion |
| Earnings before Tax | -925 Million | 369 Million | -127 Million | 7.24 Billion | 251 Million | 4.86 Billion |
| Net Income | -891 Million | 201 Million | 347 Million | 5.5 Billion | -92 Million | 3.64 Billion |
| Earnings Per Share Basic | -7.14 | 1.61 | 2.78 | - | -0.74 | 29.19 |
| Earnings Per Share Diluted | -7.14 | 1.61 | 2.76 | - | -0.74 | 29.05 |
| Weighted Average Shares Outstanding | 124.82 Million | 124.81 Million | 125.74 Million | 124.79 Million | 124.8 Million | 124.8 Million |
| Weighted Average Shares Outstanding (Diluted) | 124.82 Million | 124.84 Million | 125.38 Million | 125.39 Million | 124.8 Million | 125.39 Million |
| Gross Margin | 0.73 | 0.72 | 0.65 | 0.73 | 0.73 | 0.81 |
| EBIT Margin | -0.02 | 0.04 | 0.07 | - | 0.20 | 0.36 |
| Profit Margin | -0.10 | 0.02 | 0.04 | 0.13 | -0.01 | 0.27 |
| EBITDA | -163 Million | 316 Million | 649 Million | - | 1.84 Billion | 4.88 Billion |
| Earnings Before Tax Margin | -0.05 | -0.06 | -0.03 | 0.18 | 0.10 | 0.36 |
DARK
WINTW
9441
FTC
6582
0IP1